Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0780 Effect on Blood Pressure in ASCVD Patients
NCT06692764Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2024
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
A Phase 2 trial of laroprovstat in hypercholesterolemia, sponsored by AstraZeneca. Started Oct 2024; status: completed.
02
Drugs
laroprovstat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06692764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06692764.